Cargando…
P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY
Autores principales: | Trněný, M., Fogliatto, L., Gardner, F., Flinn, I., Larouche, J.-F., Haioun, C., Canales, M., Goto, H., Hajek, R., Salles, G., Qiu, J., Campinha-Bacote, A., Yan, M., Kothari, R., Man, G., Sahin, D., Hirata, J., Lee, C., Tilly, H., Flowers, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430670/ http://dx.doi.org/10.1097/01.HS9.0000847628.92742.d0 |
Ejemplares similares
-
P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL
por: Song, Y., et al.
Publicado: (2022) -
Status of the Polarix-TDS Project
por: Craievich, Paolo, et al.
Publicado: (2018) -
P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL
por: Morschhauser, F., et al.
Publicado: (2022) -
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial
por: Song, Yuqin, et al.
Publicado: (2023) -
The PolariX-TDS Project: Bead-Pull Measurements and High-Power Test on the Prototype
por: Craievich, Paolo, et al.
Publicado: (2019)